RBC Capital Reiterates Outperform Rating on Definium Therapeutics Inc (DFTX), sees favorable set up May 8, 2026 06:32AM
Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c May 7, 2026 04:20PM
Definium Therapeutics (DFTX) Reiterated at Buy by Stifel After Analyst Day Apr 24, 2026 08:03AM
H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX) Apr 24, 2026 06:41AM
Piper Sandler Reiterates Overweight Rating on Definium Therapeutics Inc (DFTX) Apr 23, 2026 09:15AM


Apr 22, 2026 04:15PM Definium Therapeutics updates DT120 clinical trials and commercial plans
Apr 20, 2026 06:08AM Psychedelic stocks soar after Trump signs executive order to fast-track treatments
Apr 16, 2026 04:15PM Stifel Starts Definium Therapeutics Inc (DFTX) at Buy
Apr 16, 2026 11:53AM White House Prepares Order On Ibogaine Psychedelic - CBS
Apr 10, 2026 01:54AM Piper Sandler Starts Definium Therapeutics Inc (DFTX) at Overweight
Mar 31, 2026 07:01AM Definium study shows anxiety disorder prevalence rose to 6.6% in 2023
Feb 24, 2026 09:19AM Wolfe Research Starts Definium Therapeutics Inc (DFTX) at Outperform, Top Pick
Feb 2, 2026 07:24AM Definium Therapeutics (DFTX) Reiterated at Overweight by Cantor Fitzgerald
Jan 30, 2026 01:02AM Jefferies Starts Definium Therapeutics Inc (DFTX) at Buy
Jan 23, 2026 06:09AM Definium Therapeutics Inc (DFTX) PT Raised to $36 at RBC Capital
Jan 20, 2026 07:01AM Definium Therapeutics launches educational campaign on LSD research
Jan 13, 2026 07:01AM Definium Therapeutics delays ticker change to DFTX until January 15